- Peter J Goadsby, professor 1,
- Jay Goldberg, associate professor2,
- Stephen D Silberstein, professor3
- 1Headache Group, Department of Neurology, University of California, San Francisco, CA 94143-0114, USA
- 2Department of Obstetrics and Gynecology, Jefferson Medical College, Philadelphia, PA
- 3Jefferson Headache Center, Philadelphia, PA
- Correspondence to: P J Goadsby, Headache Group, Department of Neurology, University of California, San Francisco, 505 Parnassus Ave, San Francisco CA 94143-0114 USA peter.goadsby{at}ucsf.edu
- Accepted 5 March 2008
Migraine is common, with a one year prevalence of 12-15% in the Western world.1 The case described here (see the Scenario box) illustrates many of the problems that arise when a patient who has migraines becomes pregnant.
Scenario
A 32 year old woman with a history of episodic headache has recently become aware she is pregnant. She has had troublesome headaches from childhood. She has no other medical problems. Her sister and mother have migraines. She is a non-smoker. In the previous five years, her headaches have become more frequent, with five to seven attacks a month of disabling left or right sided, throbbing pain around the parietal and temporal region. The pain is aggravated by physical activity and any movement and associated with nausea and marked vomiting, prominent photophobia, and phonophobia. The attacks last two to three days. She had no aura symptoms. Neurological and general physical examinations were normal, and thus her diagnosis is migraine without aura.2
She has had minimal benefit from over the counter analgesics, including paracetamol (acetaminophen) with and without codeine; aspirin; metoclopramide; prochlorperazine; domperidone; and non-steroidal anti-inflammatory drugs (notably ibuprofen and naproxen). She was started on sumatriptan 20 mg nasal spray. This provided headache relief in about two hours, with some mild chest discomfort. She was also started on topiramate as a migraine preventive, which, at a dose of 50 mg twice daily, reduced her attack frequency to two a month. Breakthrough attacks were treated with sumatriptan. She had some mild paraesthesia with topiramate but no other side effects. This pregnancy, her first, was unplanned. She is currently …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012